A Dose Finding Study to Treat Bone Tumor(s)
NCT06008483
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Bone Cancer
Bone Tumor
Solid Tumor
Metastatic Cancer to the Bone
Metastatic Tumor to the Bone
Interventions
DRUG:
153-Sm-DOTMP (Samarium-153-DOTMP)
Sponsor
QSAM Therapeutics, Inc.